Pulse Biosciences(PLSE),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community - To The Moon

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

PLSE Pulse Biosciences

Pre-Mkt 03-02 06:25:16 EST

18.73

-0.56

-2.90%

盘前18.01

-0.72-3.84%

04:11 EST

High19.57	Low18.54	Vol166.27K
Open18.94	D1 Closing19.29	Amplitude5.35%
Mkt Cap1.27B	Tradable Cap326.62M	Total Shares67.77M
T/O3.13M	T/O Rate0.95%	Tradable Shares17.44M
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

Loading ...

{"stockData":{"symbol":"PLSE","market":"US","secType":"STK","nameCN":"Pulse Biosciences","latestPrice":18.73,"timestamp":1772226000000,"preClose":19.29,"halted":0,"volume":166268,"hourTrading":{"tag":"盘前","latestPrice":18.01,"preClose":18.73,"latestTime":"04:11 EST","volume":4,"amount":72,"timestamp":1772442679766,"change":-0.72,"changeRate":-0.038441,"amplitude":0.001068},"delay":0,"changeRate":-0.029030585795749027,"floatShares":17438312,"shares":67767578,"eps":-1.079911,"marketStatus":"Pre-Mkt","change":-0.56,"latestTime":"03-02 06:25:16 EST","open":18.94,"high":19.572,"low":18.54,"amount":3128438.1664480004,"amplitude":0.053499,"askPrice":29.96,"askSize":200,"bidPrice":14.42,"bidSize":100,"shortable":3,"etf":0,"ttmEps":-1.079911,"tradingStatus":1,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1772461800000},"marketStatusCode":1,"adr":0,"adrRate":0,"listingDate":1463544000000,"exchange":"NASDAQ","adjPreClose":18.73,"preHourTrading":{"tag":"盘前","latestPrice":18.01,"preClose":18.73,"latestTime":"04:11 EST","volume":4,"amount":72,"timestamp":1772442679766,"change":-0.72,"changeRate":-0.038441,"amplitude":0.001068},"postHourTrading":{"tag":"盘后","latestPrice":18.36,"preClose":18.73,"latestTime":"19:36 EST","volume":1735,"amount":32411.03,"timestamp":1772238974734,"change":-0.37,"changeRate":-0.019754,"amplitude":0.019754},"volumeRatio":0.3115450329703807,"impliedVol":0.3952,"impliedVolPercentile":0.228},"requestUrl":"/m/hq/s/PLSE/tweets","defaultTab":"tweets","newsList":[{"id":"2614816522","title":"Pulse Biosciences (PLSE) Is Down 12.6% After Wider Losses And New Funding Plans - Has The Bull Case Changed?","url":"https://stock-news.laohu8.com/highlight/detail?id=2614816522","media":"Simply Wall St.","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2614816522?lang=en_us&edition=fundamental","pubTime":"2026-02-28 17:28","pubTimestamp":1772270910,"startTime":"0","endTime":"0","summary":"Pulse Biosciences, Inc. reported a full-year 2025 net loss of US$72.78 million, widening from US$53.59 million in 2024, and filed new universal and ESOP-related shelf registrations alongside a reconfigured at-the-market common stock offering.\nAt the same time, FDA approval to begin a paroxysmal atrial fibrillation study with the nPulse Cardiac Catheter System and a planned thyroid cancer collaboration with The University of Texas MD Anderson Cancer Center underscore how the company is...","market":"hk","thumbnail":"https://images.simplywall.st/asset/industry/6021000-choice1-main-header/1585186659638","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6021000-choice1-main-header/1585186659638"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/healthcare/nasdaq-plse/pulse-biosciences/news/pulse-biosciences-plse-is-down-126-after-wider-losses-and-ne","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/healthcare/nasdaq-plse/pulse-biosciences/news/pulse-biosciences-plse-is-down-126-after-wider-losses-and-ne","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK4082","PLSE"],"gpt_icon":0},{"id":"2614938488","title":"Pulse Biosciences Announces Resignation of Chief Commercial Officer","url":"https://stock-news.laohu8.com/highlight/detail?id=2614938488","media":"TIPRANKS","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2614938488?lang=en_us&edition=fundamental","pubTime":"2026-02-28 06:52","pubTimestamp":1772232778,"startTime":"0","endTime":"0","summary":"The latest announcement is out from Pulse Biosciences ( ($PLSE) ). On February 27, 2026, Pulse Biosciences, Inc. announced that Chief Commercial Of...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/pulse-biosciences-announces-resignation-of-chief-commercial-officer?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/pulse-biosciences-announces-resignation-of-chief-commercial-officer?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["PLSE","BK4082"],"gpt_icon":0},{"id":"2614898342","title":"Pulse Biosciences Chief Commercial Officer Kevin P. Danahy Resigns Immediately","url":"https://stock-news.laohu8.com/highlight/detail?id=2614898342","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2614898342?lang=en_us&edition=fundamental","pubTime":"2026-02-28 06:27","pubTimestamp":1772231238,"startTime":"0","endTime":"0","summary":"Pulse Biosciences Inc. announced that Kevin P. Danahy has resigned as Chief Commercial Officer, effective immediately. The company said his departure was not due to any disagreement related to its operations, policies, practices, or accounting.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Pulse Biosciences Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on February 27, 2026, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260227:nNDL3T9CQ0:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4082","PLSE"],"gpt_icon":0},{"id":"2613721752","title":"Pulse Biosciences Chief Commercial Officer Kevin Patrick Danahy Disposes of Common Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2613721752","media":"Reuters","labels":["shareholding","insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2613721752?lang=en_us&edition=fundamental","pubTime":"2026-02-24 09:56","pubTimestamp":1771898166,"startTime":"0","endTime":"0","summary":"Kevin Patrick Danahy, Chief Commercial Officer of Pulse Biosciences Inc., reported a disposal of common shares. The full filing can be accessed through the link below.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Pulse Biosciences Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on February 23, 2026, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260224:nNDL2Q8TfV:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"Pulse Biosciences Chief Commercial Officer Kevin Patrick Danahy Disposes of Common Shares","news_tag":"shareholding,insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PLSE","BK4082"],"gpt_icon":0},{"id":"2613297389","title":"Pulse Biosciences Grants 19,000 Inducement Stock Options to New Hires","url":"https://stock-news.laohu8.com/highlight/detail?id=2613297389","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2613297389?lang=en_us&edition=fundamental","pubTime":"2026-02-21 05:05","pubTimestamp":1771621516,"startTime":"0","endTime":"0","summary":"Pulse Biosciences granted inducement stock options to two new employees covering an aggregate of 19,000 shares. The options have an exercise price of $25.46 per share and vest over four years, with one-quarter vesting each year, subject to continued employment.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260220:nNDL45RQjh:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4082","PLSE"],"gpt_icon":0},{"id":"1192854199","title":"Stock Track | Pulse Biosciences Plummets 5.06% Intraday as Profit-Taking Follows Strong Quarterly Gains Despite Earnings Beat","url":"https://stock-news.laohu8.com/highlight/detail?id=1192854199","media":"Stock Track","labels":["movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1192854199?lang=en_us&edition=fundamental","pubTime":"2026-02-20 22:32","pubTimestamp":1771597955,"startTime":"0","endTime":"0","summary":"Pulse Biosciences stock plummeted 5.06% during intraday trading on Friday, marking a sharp reversal after the company reported quarterly results that beat analyst expectations.The medical technology...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_en","symbols":["PLSE"],"gpt_icon":0},{"id":"2612626732","title":"Pulse Biosciences Inc. : Oppenheimer Raises Target Price to $30 From $22","url":"https://stock-news.laohu8.com/highlight/detail?id=2612626732","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2612626732?lang=en_us&edition=fundamental","pubTime":"2026-02-20 21:19","pubTimestamp":1771593578,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260220:nAZN4SHMMG:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["PLSE","BK4082"],"gpt_icon":0},{"id":"2612826477","title":"Mizuho Securities Sticks to Their Buy Rating for Pulse Biosciences (PLSE)","url":"https://stock-news.laohu8.com/highlight/detail?id=2612826477","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2612826477?lang=en_us&edition=fundamental","pubTime":"2026-02-20 20:45","pubTimestamp":1771591540,"startTime":"0","endTime":"0","summary":"In a report released today, Anthony Petrone from Mizuho Securities reiterated a Buy rating on Pulse Biosciences, with a price target of $30.00. Acc...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/mizuho-securities-sticks-to-their-buy-rating-for-pulse-biosciences-plse-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/mizuho-securities-sticks-to-their-buy-rating-for-pulse-biosciences-plse-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["MFG","PLSE"],"gpt_icon":0},{"id":"2612261306","title":"Pulse Biosciences to Present at TD Cowen Healthcare Conference","url":"https://stock-news.laohu8.com/highlight/detail?id=2612261306","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2612261306?lang=en_us&edition=fundamental","pubTime":"2026-02-20 20:00","pubTimestamp":1771588830,"startTime":"0","endTime":"0","summary":"Pulse Biosciences to Present at TD Cowen Healthcare Conference               Pulse Biosciences Inc. will present at the 46th Annual TD Cowen Healthcare Conference in Boston on Wednesday, March 4, 2026","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260220:nNDL7XWZHd:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PLSE","BK4082"],"gpt_icon":0},{"id":"2612235784","title":"BRIEF-Pulse Biosciences Says It Enters Equity Distribution Agreement With TD Securities","url":"https://stock-news.laohu8.com/highlight/detail?id=2612235784","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2612235784?lang=en_us&edition=fundamental","pubTime":"2026-02-20 05:44","pubTimestamp":1771537444,"startTime":"0","endTime":"0","summary":"BRIEF-Pulse Biosciences Says It Enters Equity Distribution Agreement With TD Securities Feb 19  - Pulse Biosciences Inc PLSE.O:PULSE BIOSCIENCES INC - ENTERS EQUITY DISTRIBUTION AGREEMENT WITH TD SECURITIES - SEC FILINGPULSE BIOSCIENCES INC - MAY SELL SHARES WORTH UP TO ABOUT $60 MILLION - SEC FILINGSource text: [ID:n0001437749-26-004726]Further company coverage: PLSE.O ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260219:nFWN3ZF1EE:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PLSE","BK4082"],"gpt_icon":0},{"id":"2612323525","title":"Pulse Biosciences Establishes New $60 Million ATM Program","url":"https://stock-news.laohu8.com/highlight/detail?id=2612323525","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2612323525?lang=en_us&edition=fundamental","pubTime":"2026-02-20 05:37","pubTimestamp":1771537038,"startTime":"0","endTime":"0","summary":"Pulse Biosciences ( ($PLSE) ) has provided an update. On February 19, 2026, Pulse Biosciences entered into a new equity distribution agreement with...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/pulse-biosciences-establishes-new-60-million-atm-program?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/pulse-biosciences-establishes-new-60-million-atm-program?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["PLSE","BK4082"],"gpt_icon":0},{"id":"2612787233","title":"Pulse Biosciences Inc - to Offer Securities Worth $200 Mln - SEC Filing","url":"https://stock-news.laohu8.com/highlight/detail?id=2612787233","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2612787233?lang=en_us&edition=fundamental","pubTime":"2026-02-20 05:23","pubTimestamp":1771536224,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260219:nFWN3ZF1CE:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4082","PLSE"],"gpt_icon":0},{"id":"2612337233","title":"Pulse Biosciences Inc - Enters Equity Distribution Agreement With TD Securities - SEC Filing","url":"https://stock-news.laohu8.com/highlight/detail?id=2612337233","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2612337233?lang=en_us&edition=fundamental","pubTime":"2026-02-20 05:13","pubTimestamp":1771535628,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260219:nFWN3ZF1EE:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4082","PLSE"],"gpt_icon":0},{"id":"2612233312","title":"Pulse Biosciences Inc - May Sell Shares Worth up to About $60 Mln - SEC Filing","url":"https://stock-news.laohu8.com/highlight/detail?id=2612233312","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2612233312?lang=en_us&edition=fundamental","pubTime":"2026-02-20 05:13","pubTimestamp":1771535628,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260219:nFWN3ZF1EE:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["PLSE","BK4082"],"gpt_icon":0},{"id":"2612380842","title":"Pulse Biosciences posts FY 2025 GAAP net loss of USD 72.8 million (+36%)","url":"https://stock-news.laohu8.com/highlight/detail?id=2612380842","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2612380842?lang=en_us&edition=fundamental","pubTime":"2026-02-20 05:09","pubTimestamp":1771535375,"startTime":"0","endTime":"0","summary":"Pulse Biosciences posts FY 2025 GAAP net loss of USD 72.8 million (+36%)               Pulse Biosciences reported FY 2025 revenue of USD 350 thousand and Q4 2025 revenue of USD 264 thousand, up 3.07x ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260219:nNDL303BT3:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PLSE","BK4082"],"gpt_icon":0},{"id":"2612384802","title":"Pulse Biosciences Q4 EPS $(0.26) Beats $(0.31) Estimate, Sales $264.000K Beat $250.000K Estimate","url":"https://stock-news.laohu8.com/highlight/detail?id=2612384802","media":"Benzinga","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2612384802?lang=en_us&edition=fundamental","pubTime":"2026-02-20 05:07","pubTimestamp":1771535275,"startTime":"0","endTime":"0","summary":"Pulse Biosciences (NASDAQ:PLSE) reported quarterly losses of $(0.26) per share which beat the analyst consensus estimate of $(0.31) by 16.13 percent. This is a 16.13 percent increase over losses of $(0.31) per share from","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/news/earnings/26/02/50734960/pulse-biosciences-q4-eps-0-26-beats-0-31-estimate-sales-264-000k-beat-250-000k-estimate","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"Pulse Biosciences Q4 EPS $(0.26) Beats $(0.31) Estimate, Sales $264.000K Beat $250.000K Estimate","news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PLSE"],"gpt_icon":0},{"id":"2612238199","title":"BRIEF-Pulse Biosciences Q4 Income From Operations USD -18.253 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2612238199","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2612238199?lang=en_us&edition=fundamental","pubTime":"2026-02-20 05:05","pubTimestamp":1771535147,"startTime":"0","endTime":"0","summary":"BRIEF-Pulse Biosciences Q4 Income From Operations USD -18.253 Million\n\n\nFeb 19 (Reuters) - Pulse Biosciences Q4 net income USD -17.433 million.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260219:nPLXC6F960:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PLSE","BK4082"],"gpt_icon":0},{"id":"2612238940","title":"Pulse Biosciences Q4 Net Income USD -17.433 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2612238940","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2612238940?lang=en_us&edition=fundamental","pubTime":"2026-02-20 05:05","pubTimestamp":1771535103,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260219:nPLXC6F960:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4082","PLSE"],"gpt_icon":0},{"id":"2612928794","title":"Pulse Biosciences Chief Commercial Officer Kevin Patrick Danahy Reports Disposal of Common Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2612928794","media":"Reuters","labels":["shareholding","insiderTrades","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2612928794?lang=en_us&edition=fundamental","pubTime":"2026-02-18 09:48","pubTimestamp":1771379304,"startTime":"0","endTime":"0","summary":"Kevin Patrick Danahy, Chief Commercial Officer of Pulse Biosciences Inc., reported a disposal of common shares of the company. The full filing can be accessed through the link below.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Pulse Biosciences Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on February 17, 2026, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260218:nNDL8GLwCg:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"Pulse Biosciences Chief Commercial Officer Kevin Patrick Danahy Reports Disposal of Common Shares","news_tag":"shareholding,insiderTrades,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PLSE","BK4082"],"gpt_icon":0},{"id":"1142550746","title":"Earning Preview: Pulse Biosciences this quarter’s revenue is expected to increase by 0%, and institutional views are bullish","url":"https://stock-news.laohu8.com/highlight/detail?id=1142550746","media":"Earnings Agent","labels":["earningPreview"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1142550746?lang=en_us&edition=fundamental","pubTime":"2026-02-12 14:33","pubTimestamp":1770877998,"startTime":"0","endTime":"0","summary":"Abstract Pulse Biosciences will release its quarterly results on February 19, 2026 Post Market; investors are watching revenue traction, margin stabilization, and updates on nPulse cardiac catheter...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"Earning Preview: Pulse Biosciences this quarter’s revenue is expected to increase by 0%, and institutional views are bullish","news_tag":"earningPreview","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PLSE"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.pulsebiosciences.com","stockEarnings":[{"period":"1week","weight":-0.1256},{"period":"1month","weight":0.3823},{"period":"3month","weight":0.3682},{"period":"6month","weight":0.2053},{"period":"1year","weight":0.0213},{"period":"ytd","weight":0.3642}],"compareEarnings":[{"period":"1week","weight":-0.005},{"period":"1month","weight":-0.0136},{"period":"3month","weight":0.0038},{"period":"6month","weight":0.0635},{"period":"1year","weight":0.1725},{"period":"ytd","weight":0.006}],"compareStock":{"symbol":"SPY","name":"SPDR S&P 500 ETF Trust"},"description":"Pulse Biosciences, Inc. operates as a novel bioelectric medicine company. It offers CellFX System, a tunable, software-enabled, and console-based platform that delivers nano second duration pulses of electrical energy to non-thermally clear targeted cells while sparing adjacent non-cellular tissue to treat a various medical condition by using its Nano-Pulse Stimulation technology. The company was formerly known as Electroblate, Inc. and changed its name to Pulse Biosciences, Inc. in December 2015. The company was incorporated in 2014 and is headquartered in Hayward, California.","yearOnYearQuotes":[{"month":1,"riseRate":0.7,"avgChangeRate":0.039406},{"month":2,"riseRate":0.4,"avgChangeRate":0.027622},{"month":3,"riseRate":0.333333,"avgChangeRate":0.004346},{"month":4,"riseRate":0.555556,"avgChangeRate":0.123266},{"month":5,"riseRate":0.333333,"avgChangeRate":0.00138},{"month":6,"riseRate":0.5,"avgChangeRate":0.006609},{"month":7,"riseRate":0.5,"avgChangeRate":0.013289},{"month":8,"riseRate":0.6,"avgChangeRate":0.001957},{"month":9,"riseRate":0.5,"avgChangeRate":0.125621},{"month":10,"riseRate":0.3,"avgChangeRate":0.008129},{"month":11,"riseRate":0.5,"avgChangeRate":0.107856},{"month":12,"riseRate":0.6,"avgChangeRate":0.087874}],"exchange":"NASDAQ","name":"Pulse Biosciences","nameEN":"Pulse Biosciences"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.36.2","shortVersion":"4.36.2","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Pulse Biosciences(PLSE),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest Pulse Biosciences(PLSE) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"Pulse Biosciences,PLSE,Pulse Biosciences股票,Pulse Biosciences股票老虎,Pulse Biosciences股票老虎国际,Pulse Biosciences行情,Pulse Biosciences股票行情,Pulse Biosciences股价,Pulse Biosciences股市,Pulse Biosciences股票价格,Pulse Biosciences股票交易,Pulse Biosciences股票购买,Pulse Biosciences股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Pulse Biosciences(PLSE),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest Pulse Biosciences(PLSE) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}